GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.

GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.

AIMS/HYPOTHESIS: Latent autoimmune diabetes in adults (LADA) is a slowly progressive form of autoimmune diabetes, with autoantibodies to islet proteins developing in older patients who have no immediate requirement for insulin therapy. Markers of its clinical course are uncharacterised. The aim of t...

Full description

Bibliographic Details
Main Authors:	Desai, M, Cull, C, Horton, V, Christie, MR, Bonifacio, E, Lampasona, V, Bingley, P, Levy, J, Mackay, I, Zimmet, P, Holman, R, Clark, A
Format:	Journal article
Language:	English
Published:	2007

Similar Items

GAD65 autoantibody titres at diagnosis in Latent Autoimmune Diabetes in Adults (LADA) differ from Type 1 diabetes (T1D) and together with epitope specificity predict insulin requirement
by: Desai, M, et al.
Published: (2004)

Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS
by: Clark, A, et al.
Published: (2005)

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
by: Turner, R, et al.
Published: (1997)

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
by: Horton, V, et al.
Published: (1999)

Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
by: Davison, L, et al.
Published: (2008)

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
by: Turner, R, et al.
Published: (1997)

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43)
by: Horton, V, et al.
Published: (1999)

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).
by: Bottazzo, G, et al.
Published: (2005)

Susceptibility effects of variation at the IDDM2 (Insulin-gene) locus in latent autoimmune diabetes in adults (LADA).
by: Desai, M, et al.
Published: (2003)

An association analysis of the HLA gene region in latent autoimmune diabetes in adults.
by: Desai, M, et al.
Published: (2007)

Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
by: Davis, T, et al.
Published: (2005)

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (vol 48, pg 703, 2005)
by: Bottazzo, G, et al.
Published: (2005)

Erratum: IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (Diabetologia (2005) 48 (703-708) DOI: http://dx.doi.org/10.1007/s00125-005-1691-9)
by: Bottazzo, G, et al.
Published: (2005)

Glucose control in UKPDS type 2 diabetic patients with and without autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase.
by: Mehta, Z, et al.
Published: (1999)

Genetic and immunological characterisation of patients with latent autoimmune diabetes in adults (LADA)
by: Desai, M, et al.
Published: (2005)

Autoantibodies in neuromuscular autoimmune disorders.
by: Lang, B, et al.
Published: (2006)

Autoantibody reactivity to tetraspanin-7 is directed to the cytoplasmic domains: Implications for immunoassay design
by: McLaughlin, KA, et al.
Published: (2018)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
by: Turner, R, et al.
Published: (1999)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
by: Cull, C, et al.
Published: (2004)

The variable number of tandem repeats upstream of the insulin gene is a susceptibility locus for latent autoimmune diabetes in adults.
by: Desai, M, et al.
Published: (2006)

Fine specificity of autoantibodies to calreticulin: Epitope mapping and characterization.
by: Khamashta, M, et al.
Published: (1998)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
by: Cull, C, et al.
Published: (2001)

Fine specificity of autoantibodies to calreticulin: epitope mapping and characterization.
by: Eggleton, P, et al.
Published: (2000)

Autoantibodies against neurologic antigens in nonneurologic autoimmunity
by: Stathopoulos, P, et al.
Published: (2019)

CXCL13 levels and autoantibody epitope specificities in LGI1-autoantibody syndromes
by: Michael, S, et al.
Published: (2019)

Ethnic differences in diabetic nephropathy - The UKPDS
by: Stevens, R, et al.
Published: (1999)

Remnant epitopes, autoimmunity and glycosylation.
by: Opdenakker, G, et al.
Published: (2006)

Control of autoimmunity by "epitope theft".
by: Kranc, K, et al.
Published: (2005)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
by: Matthews, DR, et al.
Published: (1998)

Autoantibodies and autoimmunity : molecular mechanisms in health and disease /
by: Pollard, K. Michael (Kenneth Michael)
Published: (2006)

The role of anti-glutamic acid decarboxylase autoantibodies (GAD-Ab) in idiopathic late onset cerebellar ataxia (ILOCA)
by: Muzaimi, M, et al.
Published: (2004)

Variation at the insulin VNTR locus but not the CTLA-4 locus is associated with age of onset and need for insulin therapy in latent autoimmune diabetes in adults (LADA)
by: Horton, V, et al.
Published: (2001)

Aplikasi Seromarker Autoantibody Pada Penderita Hepatitis Autoimmune
by: Perpustakaan UGM, i-lib
Published: (2006)

Postpartum GAD is a risk factor for postpartum MDD: The course and longitudinal relationships of postpartum GAD and MDD
by: Prenoveau, J, et al.
Published: (2013)

Postpartum GAD is a risk factor for postpartum MDD: the course and longitudinal relationships of postpartum GAD and MDD.
by: Prenoveau, J, et al.
Published: (2013)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
by: Cull, C, et al.
Published: (1995)

Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetes.
by: Davis, T, et al.
Published: (2003)

Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes
by: McLaughlin, K, et al.
Published: (2016)

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
by: Turner, R, et al.
Published: (1991)

Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90)
by: Leal, J, et al.
Published: (2021)